Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VHM in HIV Control After Treatment Interruption
NCT02475915Phase 2Completed
- Sponsor
- SEARCH Research Foundation
- Start
- Jan 2015
- Primary completion
- Nov 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat, hydroxychloroquine, maraviroc in human immunodeficiency virus infection (HIV), sponsored by SEARCH Research Foundation. Started Jan 2015; status: completed.
02
Drugs
vorinostathydroxychloroquinemaraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02475915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02475915.